News

Feb 2016

In December 2015, EpiConcept was entrusted with an expertise mission sponsored by the WHO (World Health Organisation) to create a protocol for evaluating the direct and indirect effects of the pneumococcal conjugate vaccine (PCV) andthe anti-rotavirus vaccine for the Morrocan ministry of health. This mission has engaged the services of three epidemiologists from EpiConcept’s epidemiology department. The mission is planned to conclude this month.

Jan 2016

The centres for free and anonymous HIV screening (CDAG) and for information, screening and diagnostics of STDs (CIDDIST) from the Melun Hospital centre, Meulan-les-Mureaux hospital center, the French Red Cross of Paris, Toulouse university hospital centre, and the Paris social, children, and health action directorate have migrated to the new version of EpiConcept's CUPIDON information system as part of their accreditation to Free Centres for Screening and Diagnostics (CeGIDD). These centers now benefit from all the new functionalities specifically put in place for the CeGIDD centres.

Jan 2016

The Toulon university hospital centre has chosen EpiConcept’s Cupidon web application as its IT solution for anonymous screening and diagnosis of sexually transmitted infections (CeGIDD). The solution allows the centre to manage all the consultations from the initial intake to the delivery of the results. The system will also automatically create quarterly activity results for the center and allow the user to consult an activity dashboard. This simple solution which is adapted to the screening center’s activities is an on-line web application made possible by EpiConcept’s ministry of health certification as a “Personal health data hosting provider”.

Dec 2015

The 2015 annual ESCAIDE (European Scientific Conference on Applied Infectious Disease Epidemiology) conférence took place on November 11-13 in Stockholm. Epidemiologists from EpiConcept and the Indian Ocean Commission's Sage project "One Health" (coordinated by EpiConcept) presented results in the form of oral presentations and posters.

SESSION PRESENTATIONS (abstracts here)

  • Esther Kissling - Influenza vaccine effectiveness (VE) estimates from the I-MOVE multicentre case control study in Europe, 2014-15: low vaccine effectiveness against A(H3N2) and moderate vaccine effectiveness against A(H1N1)pdm09 and B
  • Germaine Hanquet - Indirect effect of childhood PCV10/13 vaccination on invasive pneumococcal disease among seniors 65 years old and over in six European countries (Spidnet network): Implications for PCV13 vaccination of the elderly
  • IOC - Alain RAKOTOARISOA - Bubonic plague outbreak investigation in the endemic district of Tsiroanomandidy - Madagascar, October 2014 (also presented in Mexico City at the 8th TEPHINET Global Conference 7-11 September 2015)
  • IOC - Lala Harisoa Rabetaliana - Pneumonic plague outbreak following case migration from the endemic highlands – municipality of Ambaohoabe, Madagascar, December 2013

POSTER PRESENTATIONS

  • Marc Rondy - High and rapid effectiveness of polysaccharide vaccines against clinical meningitis in Niger, 2015.
  • IOC- Rado Randriamiarana  - Evaluation of the reinforced Integrated Disease Surveillance and Response strategy using short message service data transmission in two southern regions of Madagascar, 2014-5. Presented by Ariane Halm.
  • IOC -Mireille Randria -  One year of sentinel surveillance of malaria and severe acute respiratory hospitalisations and deaths in Madagascar, September 2014 - August 2015.  Presented by Alain Rakotoarisoa.
  • IOC - Mireille Randria - Worrying resurgence of severe malaria in non-endemic area: Case of the hospital of Fianarantsoa, ​​from  October 2014 to May 2015, Madagascar.  Presented by Alain Rakotoarisoa.
  • IOC - Harimahefa Razafimandimby - Household and behavioural risk factors for human plague in Madagascar, 2012-3. Presented by Lala Harisoa Rabetaliana.
  • IOC - Ariane Halm - Four years of regional field epidemiology training programme in the Indian Ocean
Dec 2015

EpiConcept is collaborating with the Moroccan ministry of health in enhancing the surveillance systems for rotavirus and invasive pneumococcal infections for evaluating the effectiveness and impact of the related vaccines between December 2014 and January 2016.

Dec 2015

The CDHS (Departmental Committee for social hygiene) has entrusted EpiConcept with the design and implementation of its electronic health records system for its six health centres in the Rhône department. The software is designed to optimize and facilitate the treatment plan, making appointments, waiting lists and the production of statistical reports. Centered around an individual patient, it covers vaccination, pulmonology, smoking issues, social aspects  and the management of inquiries into tuberculosis cases (DAMOC). Based on EpiConcept’s Voozanoo plateform, it benefits from the Ministry of Health’s certification for hosting personal health data. The application has been in use since October 2015.

Nov 2015

On the 26th and 27th of October, the Indian Ocean Commission (IOC) held its third scientific conference on the SEGA ONE HEALTH project. This programme’s goal is to reinforce surveillance, alerts, investigations and epidemic event responses. EpiConcept provides support for the work of the IOC’s  health surveillance unit.

Nov 2015

As part of the the Indian Ocean Commission’s (IOC) Field Epidemiology Training Programme (FETP), EpiConcept taught a one-week course in scientific communications. The trainees learned methods for both written and oral delivery. The course was held on the last week of September in the capital Antananarivo.

Nov 2015

The French ministry of health has renewed the ASIP certification of EpiConcept’s Voozanoo information system platform for hosting applications containing personal health data for another three years. The ASIP certification was initially attributed to the Voozanoo development platform in May of 2012 and is renewable every three years based upon a positive evaluation result. ASIP is the public interest group which manages the certification process for Personal health data hosting providers.

Nov 2015

Phare is a software application to register and follow up patients with a hereditary risk to cancer and to manage their personalised treatment plan. Phare is based on Voozanoo which allows each region to adapt the patient filing system to their particular practices while keeping the standard functions; management of of the personalised treatment plan, exam planning and follow-up, and postal mailings and reminder mails. The Phare application is being deployed by the “Proche” (regional prevention of hereditary cancer) network who manages patient follow-up in the Nord-Pas-de-Calais region.  Currently there are 1600 patients in the network with 400 new patients added each year.

 

Nov 2015

As part of the Cytomegalovirus (CMV) epidemiological surveillance effort in France, the National Reference Center for CMV has chosen EpiConcept’s Voozanoo platform to collect infection declaration questionnaires :

  • - Declaring  infections and suspected infections in pregnant women and newborns
    - Monitoring children with congenital infections or those acquired over 10 years

The National Reference Center teams were trained to use Voozanoo and can thus manage the declaration and follow-up questionnaire updates. The center can also put in place ad hoc questionnaires as needed.

Oct 2015

The goal of this project is to create a patient follow-up system for the 25 expert centers in the French national clinical research network on Parkinson’s disease (NS-Park, FCRIN). The application will be used as a centralised information system for medical personnel to bring together all information from among the various practitioners (Neurologists, surgeons, neuropsychologists, dieticians, chiropractors, etc.).  The creation of a common patient dossier for multiple centers will simplify follow-up for patients who move. The information system will automatically create each centre’s annual activity report for the regional health agency (ARS). As well, it will allow for patient selection (among those who consent to it) for various clinical research studies. In whole, a database to be used for research on Parkinson’s disease.
Using EpiConcept’s Voozanoo 4 as the technology platform for this will enable multi-format (tablet, netbook or computer) use depending on the equipment of each centre. More information can be found at www.parkinson.network.

Oct 2015

Following the cancer screening networks in the Gard and Lozère departments (southern France), the Drôme department’s breast cancer screening centers have implemented the e-SIS 100% digital mammography system. Having begun in September, seven radiology centers and the managing organisation DAPC based in Valence, have had this system installed. Currently, there are more than 20,000 mammograms made and managed annually with the e-SIS system.

 

About e-SIS: Since the spring of 2013, EpiConcept has been part of the European e-SIS (electronic Screening Information System) consortium whose mission is to create complete digital workflows for cancer screening organisations.

This ambitious project is the result of a collaboration among four entities:

  • EpiConcept
  • The CDI company (responsible for setting up the Swiss federation’s cancer screening information system) whose IT system has managed a 100% digital workflow for the past five years.
  • The Fribourg engineering school (for the R&D)
  • SESAM, a Turkish company specialised in IT systems integration

This project is made possible through investments by each of the parties involved and through a financing programme for innovation by EUROSTARS from the European Commission.

 

See also the article in the French newspaper Le Dauphiné from the 23rd of October "Mammographies numérisées, de nouvelle génération".

 

The piece of the information system developed by EpiConcept is based on Voozanoo.

Oct 2015

In the last ten years pertussis has re-emerged in many regions including the EU/EEA (European Union/ European Economic Area), despite high and stable vaccine coverage with the primary series of acellular pertussis vaccine. Pertussis can lead to severe disease in infants. The project “Setting up a sentinel system to assess the burden of whooping cough in EU/EEA” is a four-year project funded by the ECDC (European Centre for Disease Prevention and Control), coordinated by EpiConcept and involves 11 partners from 10 EU/EEA member states. It aims to set up a European hospital network to address key questions on the burden of pertussis in infants less than one year of age, as well as the vaccine effectiveness and impact of different pertussis vaccination strategies in the EU/EEA.

Jul 2015

The I-MOVE+ (Integrated Monitoring of Vaccines in Europe) is a consortium of 24 partners (regional and national public health Institutes, Small and Medium Enterprises, Universities) from 17 European Union / European Economic Area Member States. Its goal is to develop a sustainable platform of primary care, hospital and laboratory networks that use  validated  standardised  methods  to  evaluate existing  and  new  vaccines programmes independently from commercial interests. I-MOVE+ has received a three year grant (May 2015 - May 2018) from the European Commission (Horizon 2020) to identify, pilot test, use, and disseminate the best study designs to measure, in  the effectiveness and impact of vaccines used in the elderly population to prevent influenza and pneumococcal infections. I-MOVE+ is organised in five work packages under the coordination of EpiConcept (www.i-moveplus.eu).

Jul 2015

The Myology Institute (www.institut-myologie.org/en) is creating a natural history prospective study of 70 patients infected with spinal amyotrophy type 2 and 3. This study is coordinated by Dr. Laurent Servais. It is a multicentric study involving nine centres in three countries (France, Germany, Belgium). The principal objective of the study is to characterise the evolution of the disease in the patients, and with a secondary objective to identify the variables for prognosis and disease progression biomarquers. The Voozanoo platform, which is already being used by the Myology Institute, was chosen as the tool for data collection for this new study. The clinical research assistants will enter the responses from paper CRFs (case report forms) filled in by doctors, biologists or physical therapists at each patient visit.

Jul 2015

The REVELA 13 observatory is a surveillance programme for kidney, bladder and acute Leukaemia cancers in the Bouches-du-Rhône department of France.  It is upgrading its Voozanoo information system to a relational database with geographic metadata. Originally hosted on the InVS (French Institute for public health surveillance) Voozanoo platform, it has been migrated to EpiConcept’s hosting platform to optimize the operations performed on the collected data and to integrate geolocation. The current method requires too much manual intervention for data collection, data entry and deduplication. This project will enable faster processing of all data sent to the centre by institutions and RCPs (multidisciplinary concertation meetings).

Jul 2015

In collaboration with the WHO (World Health Organisation), an epidémiologist from EpiConcept drafted two study protocols for measuring the effectiveness of vaccines against meningococcal meningitis in Niger. The studies are currently taking place in the two districts of Niamey II et Ouallam. The studies were made for the Ministry of Health and in collaboration with the CERMES laboratory and the MenAfrinet network.

Jun 2015

During the two days of the Asia-Pacific Influenza Summit & antiviral forum (June 10 & 11) organised in Hanoi, Vietnam by APACI (Asia-Pacific Alliance for the control of influenza), EpiConcept presented the influenza vaccine effectiveness results for Europe from the years 2008 to 2015. The results of studies from the I-Move groupe were presented.

Jun 2015

As part of the continuing FETP with the Hong Kong Centre for Health Protection (http://www.chp.gov.hk/en), from the 1st to the 5th of June, EpiConcept organised and led a training workshop on investigating epidemics.